We just received data on a new analyst forecast for $ENTG. Charles Shi from Needham set a price target of 150.0 for ENTG.
To track analyst ratings and price targets for $ENTG, check out Quiver Quantitative's $ENTG forecast page.
Should you buy $ENTG?
Some analysts are better than others. To view the past performance of Needham, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$ENTG Price Targets
Multiple analysts have issued price targets for $ENTG recently. We have seen 8 analysts offer price targets for $ENTG in the last 6 months, with a median target of $118.5.
Here are some recent targets:
- Charles Shi from Needham set a target price of $150.0 on 02/10/2026
- Atif Malik from Citigroup set a target price of $145.0 on 01/27/2026
- Bhavesh Lodaya from BMO Capital set a target price of $126.0 on 01/21/2026
- Timothy Arcuri from UBS set a target price of $145.0 on 01/15/2026
- Aleksey Yefremov from Keybanc set a target price of $111.0 on 01/09/2026
- James Schneider from Goldman Sachs set a target price of $75.0 on 12/15/2025
- John Roberts from Mizuho set a target price of $96.0 on 11/20/2025
$ENTG Insider Trading Activity
$ENTG insiders have traded $ENTG stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.
Here’s a breakdown of recent trading of $ENTG stock by insiders over the last 6 months:
- BERTRAND LOY (Executive Chair) has made 0 purchases and 9 sales selling 122,820 shares for an estimated $12,230,345.
- SUSAN G. RICE (SVP, Global Human Resources) sold 8,858 shares for an estimated $707,222
- CLINTON M. HARIS (SVP & President, APS Division) sold 5,830 shares for an estimated $699,600
- JOSEPH COLELLA (SVP and General Counsel) sold 3,577 shares for an estimated $316,242
- JAMES P LEDERER sold 2,008 shares for an estimated $186,422
- OLIVIER BLACHIER (SVP, Chief Strategy Officer) sold 488 shares for an estimated $37,785
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ENTG Revenue
$ENTG had revenues of $823.9M in Q4 2025. This is a decrease of -3.05% from the same period in the prior year.
You can track ENTG financials on Quiver Quantitative's ENTG stock page.
$ENTG Congressional Stock Trading
Members of Congress have traded $ENTG stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $ENTG stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$ENTG Hedge Fund Activity
We have seen 260 institutional investors add shares of $ENTG stock to their portfolio, and 325 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL RESEARCH GLOBAL INVESTORS added 6,974,133 shares (+inf%) to their portfolio in Q3 2025, for an estimated $644,828,337
- D1 CAPITAL PARTNERS L.P. removed 3,019,633 shares (-72.4%) from their portfolio in Q3 2025, for an estimated $279,195,267
- BAILLIE GIFFORD & CO removed 2,058,007 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $190,283,327
- VAN ECK ASSOCIATES CORP added 2,053,869 shares (+1721.7%) to their portfolio in Q3 2025, for an estimated $189,900,727
- INVESCO LTD. added 2,050,473 shares (+183.5%) to their portfolio in Q3 2025, for an estimated $189,586,733
- HOLOCENE ADVISORS, LP removed 1,859,828 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $171,959,696
- FMR LLC added 1,857,388 shares (+1015.8%) to their portfolio in Q3 2025, for an estimated $171,734,094
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.